Software Company Strainprint Wants to Change the Limitations of Medical Cannabis Research

Data Investing

Meet the company collecting data sets on the use of medical cannabis in North America.


The use of cannabis as a medical tool for patients in Canada has expanded greatly thanks to the advancements of the policy implemented by the federal government as it seeks full legalization of the drug. More and more patients are looking into the potential of cannabis as a legitimate tool for combating several diseases.

With a clearer path towards medical use, data and tests are crucial for the development of cannabis in this industry–an area where the market has been severely lacking. A software company in Toronto is trying to change the shortage

... read more at: